跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-Levetiracetam Oral levetiracetam 100 mg/mL amber glass bottle - TGA Drug Approval Details
Approvals
/
TGA
/
APO-Levetiracetam Oral levetiracetam 100 mg/mL amber glass bottle
Approved
STANDARD
APO-Levetiracetam Oral levetiracetam 100 mg/mL amber glass bottle
Southern Cross Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
8f37d02c625cb39d
Company
Southern Cross Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
8f37d02c625cb39d
Product Name
APO-Levetiracetam Oral levetiracetam 100 mg/mL amber glass bottle
Artg Id
237435
Artg Name
APO-Levetiracetam Oral levetiracetam 100 mg/mL amber glass bottle
Sponsor
Southern Cross Pharma Pty Ltd
Company Detail Path
/organization/southern-cross-pharma-pty-ltd
Artg Date
2016-04-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-01866-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-01865-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
8f37d02c625cb39d
Type
Standard
Back to TGA Approvals